Thalidomide, a drug once used to alleviate morning sickness in pregnant women, exhibits distinct properties due to its ...

Cardinal Health (NYSE:CAH) is one of the best 52-week high stocks to buy, according to analysts. On June 10, analysts at TD Cowen reiterated a Buy rating and maintained a price target of $162 on the ...

Health systems across the U.S. are accelerating partnerships with tech companies to embed AI into clinical care, operations and administrative workflows. In June, Rochester, Minn.-based Mayo Clinic ...

The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Verusen, the industry leader driving AI MRO (Maintenance, Repair, and Operations) supply chain optimization, today announced it has been honored with the Top ...

Recursion Pharmaceuticals (NASDAQ: RXRX) is not the most famous artificial intelligence (AI) stock on the market, but the ...

A successful AI initiative is largely determined by the underlying quality of data. IT leaders are elevating their data lake, ...

Viseven announced a new AI agent for its content creation platform eWizard. The new agent, called eVa, is able to communicate ...

A Liverpool-based chemistry technology specialist has been acquired by a US-based group. XtalPi, a life sciences and new materials R&D platform, has announced its acquisition of Liverpool ChiroChem ...

Duquesne Family Office's billionaire chief sold every share of Wall Street's hottest artificial intelligence (AI) stock in favor of a drugmaker whose shares have surged 142% in two years.

Experts at PA Consulting offer case studies and advice for using generative AI to improve biopharma manufacturing, mitigate ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...